Stanley Druckenmiller's Duquesne Capital bought Chinese consumer and tech stocks in the second quarter, according to a filing Monday.
In the second quarter, Druckenmiller's fund increased its stake in Microsoft by 1 million shares and added 677,000 shares of Facebook.Alibaba bought Chinese com filing fund Parent quarter share stake
Washington (CNN) President Donald Trump rarely admits he's wrong -- but has the chance to belatedly condemn neo-Nazi protests at the White House Monday. When Trump has backed down Washington Post Republicans desperately want to be united.admits chance CNN Donald President rarely Trump WASHINGTON White wrong
An obscene article on the 'Daily Stormer' went too far. In the piece, Daily Stormer used obscene language in regards to Heather Heyer -- the woman who was killed in Charlottesville on Saturday after a man rammed his car into a crowd of people.agenda announcement appeal co daily Heyer obscene response Stormer Twitter
Danone's U.S.-listed shares rose nearly 7 percent percent on a report that Corvex Management now owns a stake of about $400 million and rumors surfaced of a possible takeover.
Bloomberg reported that Keith Meister's activist hedge fund has grown its stake in Danone because it thinks the company is greatly undervalued.Bloomberg Danone Heinz Kraft management shares stake Stifel takeover thinks
However, the oil and natural gas driller has made great progress in the last two years in terms of reducing costs and leverage. Chesapeake Energy has aggressively cut its costs and leverage, which will serve the oil and natural gas driller well in an environment of higher price realizations.Chesapeake Energy cost debt higher leverage made oil natural shares stock year
August 14, 2017: Here are four stocks trading with heavy volume among 120 equities making new 52-week lows in Monday’s session. Volume of about more than 30 million shares traded was 60% above the daily average of around 18.5 million.advancers closing dropped Friday Monday NASDAQ NYSE stock Volume week
In a sector where market-caps are cut in half daily and one good pick can make your portfolio for the year, Cumberland Pharmaceutical’s (CPIX) steady growth as a micro-cap biotech might raise some eyebrows. They stated their goal in to acquire and begin marketing one new product per year.Cumberland Cumberland Pharmaceutical growth pharmaceutical pipeline product quarter Revenue sales stock
Foamix Pharmaceuticals (FOMX) is a clinical stage pharmaceutical company focused on the development topical drugs for dermatological conditions. FOMX’s lead drug is FMX-101 — a topical formulation of the antibiotic minocycline — and is in Phase 3 development for the treatment of moderate-to-severe acne.drug endpoint FMX FOMX patients Phase results studies study trial
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is a recent initial public offering that could come blessed with magical upside if its possibilities blossom into a positive reality. Kala Pharma’s initial public offering of 6,900,000 shares at $15.00 per share, and the underwriters’ option, allowed the company to raise gross proceeds of approximately $103.5 million.analyst data dry eye firm IPO Kala KPI Phase post shares